{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:43:19Z","timestamp":1789148599589,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2021-03072"],"award-info":[{"award-number":["RGPIN-2021-03072"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020797","name":"NanoMedicines Innovation Network","doi-asserted-by":"publisher","award":["NanoMedicines Innovation Network"],"award-info":[{"award-number":["NanoMedicines Innovation Network"]}],"id":[{"id":"10.13039\/100020797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s13346-024-01708-5","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T17:02:32Z","timestamp":1726506152000},"page":"1739-1754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pneumolysin-responsive liposomal platform for selective treatment of Streptococcus pneumoniae"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9112-6359","authenticated-orcid":false,"given":"Ethan","family":"Watt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilinca","family":"Andriescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4729-9970","authenticated-orcid":false,"given":"Emmanuel A.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"1708_CR1","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1128\/CMR.00024-15","volume":"28","author":"KA Geno","year":"2015","unstructured":"Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, et al. Pneumococcal capsules and their types: past, present, and future. Clin Microbiol Rev. 2015;28:871\u201399.","journal-title":"Clin Microbiol Rev"},{"key":"1708_CR2","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","volume":"400","author":"KS Ikuta","year":"2022","unstructured":"Ikuta KS, Swetschinski LR, Aguilar GR, Sharara F, Mestrovic T, Gray AP, et al. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2022;400:2221\u201348.","journal-title":"Lancet"},{"key":"1708_CR3","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1016\/j.vaccine.2022.03.048","volume":"40","author":"LJ Ricketson","year":"2022","unstructured":"Ricketson LJ, Bettinger JA, Sadarangani M, Halperin SA, Kellner JD. Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: an IMPACT study. Vaccine. 2022;40:2733\u201340.","journal-title":"Vaccine"},{"key":"1708_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/pathogens12030493","volume":"12","author":"T Ono","year":"2023","unstructured":"Ono T, Watanabe M, Hashimoto K, Kume Y, Chishiki M, Okabe H, et al. Serotypes and antibiotic resistance of Streptococcus pneumoniae before and after the introduction of the 13-valent pneumococcal conjugate vaccine for adults and children in a rural area in Japan. Pathogens. 2023;12:493.","journal-title":"Pathogens"},{"key":"1708_CR5","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1016\/j.vaccine.2021.11.032","volume":"39","author":"S Nasreen","year":"2021","unstructured":"Nasreen S, Wang J, Kwong JC, Crowcroft NS, Sadarangani M, Wilson SE, et al. Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002\u20132018: a Canadian Immunization Research Network (CIRN) study. Vaccine. 2021;39:7545\u201353.","journal-title":"Vaccine"},{"key":"1708_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41429-020-0296-3","volume":"73","author":"A Leonard","year":"2020","unstructured":"Leonard A, M\u00f6hlis K, Schl\u00fcter R, Taylor E, Lalk M, Methling K. Exploring metabolic adaptation of Streptococcus pneumoniae to antibiotics. J Antibiot. 2020;73:441\u201354.","journal-title":"J Antibiot"},{"key":"1708_CR7","doi-asserted-by":"publisher","first-page":"15738","DOI":"10.3390\/ijms232415738","volume":"23","author":"J Tang","year":"2022","unstructured":"Tang J, Ouyang Q, Li Y, Zhang P, Jin W, Qu S, et al. Nanomaterials for delivering antibiotics in the therapy of pneumonia. Int J Mol Sci. 2022;23:15738.","journal-title":"Int J Mol Sci"},{"key":"1708_CR8","doi-asserted-by":"publisher","first-page":"609459","DOI":"10.3389\/fmicb.2021.609459","volume":"12","author":"M Kumar","year":"2021","unstructured":"Kumar M, Sarma DK, Shubham S, Kumawat M, Verma V, Nina PB, et al. Futuristic non-antibiotic therapies to combat antibiotic resistance: a review. Front Microbiol. 2021;12:609459.","journal-title":"Front Microbiol"},{"key":"1708_CR9","doi-asserted-by":"publisher","first-page":"116072","DOI":"10.1016\/j.ejmech.2023.116072","volume":"265","author":"S Ji","year":"2024","unstructured":"Ji S, An F, Zhang T, Lou M, Guo J, Liu K, et al. Antimicrobial peptides: an alternative to traditional antibiotics. Eur J Med Chem. 2024;265:116072.","journal-title":"Eur J Med Chem"},{"key":"1708_CR10","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/jam.13033","volume":"120","author":"JM Shin","year":"2016","unstructured":"Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL. Biomedical applications of nisin. J Appl Microbiol. 2016;120:1449\u201365.","journal-title":"J Appl Microbiol"},{"key":"1708_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/AAC.00769-09","volume":"54","author":"JA Majchrzykiewicz","year":"2010","unstructured":"Majchrzykiewicz JA, Kuipers OP, Bijlsma JJE. Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides, bacitracin, LL-37, and nisin. Antimicrob Agents Chemother. 2010;54:440\u201351.","journal-title":"Antimicrob Agents Chemother"},{"key":"1708_CR12","doi-asserted-by":"publisher","first-page":"710199","DOI":"10.3389\/fmicb.2021.710199","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang Z, He S, Wu H, Yin T, Wang L, Shan A. Nanostructured antimicrobial peptides: crucial steps of overcoming the bottleneck for clinics. Front Microbiol. 2021;12:710199.","journal-title":"Front Microbiol"},{"key":"1708_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/bcp.12356","volume":"79","author":"B Heras","year":"2015","unstructured":"Heras B, Scanlon MJ, Martin JL. Targeting virulence not viability in the search for future antibacterials. Br J Clin Pharmacol. 2015;79:208\u201315.","journal-title":"Br J Clin Pharmacol"},{"key":"1708_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1128\/MMBR.00052-12","volume":"77","author":"FC Los","year":"2013","unstructured":"Los FC, Randis TM, Aroian RV, Ratner AJ. Role of pore-forming toxins in bacterial infectious diseases. Microbiol Mol Biol Rev. 2013;77:173\u2013207.","journal-title":"Microbiol Mol Biol Rev"},{"key":"1708_CR15","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1021\/ja111110e","volume":"133","author":"D Pornpattananangkul","year":"2011","unstructured":"Pornpattananangkul D, Zhang L, Olson S, Aryal S, Obonyo M, Vecchio K, et al. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Am Chem Soc. 2011;133:4132\u20139.","journal-title":"J Am Chem Soc"},{"key":"1708_CR16","doi-asserted-by":"publisher","first-page":"1289323","DOI":"10.3389\/fbioe.2023.1289323","volume":"11","author":"Z Wu","year":"2023","unstructured":"Wu Z, Nie R, Wang Y, Wang Q, Li X, Liu Y. Precise antibacterial therapeutics based on stimuli-responsive nanomaterials. Front Bioeng Biotechnol. 2023;11:1289323.","journal-title":"Front Bioeng Biotechnol"},{"key":"1708_CR17","doi-asserted-by":"publisher","first-page":"13352","DOI":"10.1073\/pnas.1904304116","volume":"116","author":"M V\u00f6gele","year":"2019","unstructured":"V\u00f6gele M, Bhaskara RM, Mulvihill E, van Pee K, Yildiz \u00d6, K\u00fchlbrandt W, et al. Membrane perforation by the pore-forming toxin pneumolysin. Proc Natl Acad Sci. 2019;116:13352\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"1708_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2249.2004.02611.x","volume":"138","author":"RA Hirst","year":"2004","unstructured":"Hirst RA, Kadioglu A, O\u2019Callaghan C, Andrew PW. The role of pneumolysin in pneumococcal pneumonia and meningitis. Clin Exp Immunol. 2004;138:195\u2013201.","journal-title":"Clin Exp Immunol"},{"key":"1708_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijid.2019.06.025","volume":"86","author":"C Han","year":"2019","unstructured":"Han C, Zhang M. Genetic diversity and antigenicity analysis of Streptococcus pneumoniae pneumolysin isolated from children with pneumococcal infection. Int J Infect Dis. 2019;86:57\u201364.","journal-title":"Int J Infect Dis"},{"key":"1708_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/vaccines9030209","volume":"9","author":"NR Scott","year":"2021","unstructured":"Scott NR, Mann B, Tuomanen EI, Orihuela CJ. Multi-valent protein hybrid pneumococcal vaccines: a strategy for the next generation of vaccines. Vaccines. 2021;9:209.","journal-title":"Vaccines"},{"key":"1708_CR21","doi-asserted-by":"publisher","first-page":"832254","DOI":"10.3389\/fcimb.2022.832254","volume":"12","author":"J Aceil","year":"2022","unstructured":"Aceil J, Avci FY. Pneumococcal surface proteins as virulence factors, immunogens, and conserved vaccine targets. Front Cell Infect Microbiol. 2022;12:832254.","journal-title":"Front Cell Infect Microbiol"},{"key":"1708_CR22","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.3390\/nano12122044","volume":"12","author":"M Salvador","year":"2022","unstructured":"Salvador M, Marqu\u00e9s-Fern\u00e1ndez JL, Bunge A, Mart\u00ednez-Garc\u00eda JC, Turcu R, Peddis D, et al. Magnetic nanoclusters increase the sensitivity of lateral flow immunoassays for protein detection: application to pneumolysin as a biomarker for Streptococcus pneumoniae. Nanomaterials. 2022;12:2044.","journal-title":"Nanomaterials"},{"key":"1708_CR23","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1039\/C6NR08432J","volume":"9","author":"L Blanco-Covi\u00e1n","year":"2017","unstructured":"Blanco-Covi\u00e1n L, Montes-Garc\u00eda V, Girard A, Fern\u00e1ndez-Abedul MT, P\u00e9rez-Juste J, Pastoriza-Santos I, et al. Au@Ag SERRS tags coupled to a lateral flow immunoassay for the sensitive detection of pneumolysin. Nanoscale. 2017;9:2051\u20138.","journal-title":"Nanoscale"},{"key":"1708_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nbt.3037","volume":"33","author":"BD Henry","year":"2015","unstructured":"Henry BD, Neill DR, Becker KA, Gore S, Bricio-Moreno L, Ziobro R, et al. Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice. Nat Biotechnol. 2015;33:81\u20138.","journal-title":"Nat Biotechnol"},{"key":"1708_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12951-021-00775-x","volume":"19","author":"H Besan\u00e7on","year":"2021","unstructured":"Besan\u00e7on H, Babiychuk V, Larpin Y, K\u00f6ffel R, Schittny D, Brockhus L, et al. Tailored liposomal nanotraps for the treatment of streptococcal infections. J Nanobiotechnol. 2021;19:46.","journal-title":"J Nanobiotechnol"},{"key":"1708_CR26","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1021\/jacs.2c11226","volume":"145","author":"Q Shen","year":"2023","unstructured":"Shen Q, Xiong Q, Zhou K, Feng Q, Liu L, Tian T, et al. Functionalized DNA-origami-protein nanopores generate large transmembrane channels with programmable size-selectivity. J Am Chem Soc. 2023;145:1292\u2013300.","journal-title":"J Am Chem Soc"},{"key":"1708_CR27","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S1473-3099(18)30805-3","volume":"19","author":"PF Laterre","year":"2019","unstructured":"Laterre PF, Colin G, Dequin PF, Dugernier T, Boulain T, Azeredo da Silveira S, et al. CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial. Lancet Infect Dis. 2019;19:620\u201330.","journal-title":"Lancet Infect Dis"},{"key":"1708_CR28","doi-asserted-by":"publisher","first-page":"e00262","DOI":"10.1128\/mSphere.00262-19","volume":"4","author":"PS Coburn","year":"2019","unstructured":"Coburn PS, Miller FC, LaGrow AL, Land C, Mursalin H, Livingston E, et al. Disarming pore-forming toxins with biomimetic nanosponges in intraocular infections. mSphere. 2019;4:e00262\u201319.","journal-title":"mSphere"},{"key":"1708_CR29","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.3168\/jds.2016-11133","volume":"99","author":"HY Cui","year":"2016","unstructured":"Cui HY, Wu J, Lin L. Inhibitory effect of liposome-entrapped lemongrass oil on the growth of Listeria monocytogenes in cheese. J Dairy Sci. 2016;99:6097\u2013104.","journal-title":"J Dairy Sci"},{"key":"1708_CR30","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1039\/C5RA22098J","volume":"6","author":"L Lin","year":"2016","unstructured":"Lin L, Zhang X, Zhao C, Cui H. Liposome containing nutmeg oil as the targeted preservative against Listeria monocytogenes in dumplings. RSC Adv. 2016;6:978\u201386.","journal-title":"RSC Adv"},{"key":"1708_CR31","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.2147\/JMDH.S313968","volume":"14","author":"A Tewabe","year":"2021","unstructured":"Tewabe A, Abate A, Tamrie M, Seyfu A, Abdela Siraj E. Targeted drug delivery - from magic bullet to nanomedicine: principles, challenges, and future perspectives. J Multidiscip Healthc. 2021;14:1711\u201324.","journal-title":"J Multidiscip Healthc"},{"key":"1708_CR32","doi-asserted-by":"publisher","first-page":"e170499","DOI":"10.1172\/JCI170499","volume":"133","author":"MA Ghonim","year":"2023","unstructured":"Ghonim MA, Boyd DF, Flerlage T, Thomas PG. Pulmonary inflammation and fibroblast immunoregulation: from bench to bedside. J Clin Invest. 2023;133:e170499.","journal-title":"J Clin Invest"},{"key":"1708_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.foodres.2010.10.012","volume":"44","author":"V Sant\u2019Anna","year":"2011","unstructured":"Sant\u2019Anna V, Malheiros PS, Brandelli A. Liposome encapsulation protects bacteriocin-like substance P34 against inhibition by Maillard reaction products. Food Res Int. 2011;44:326\u201330.","journal-title":"Food Res Int"},{"key":"1708_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2144\/000114190","volume":"57","author":"WT Yap","year":"2014","unstructured":"Yap WT, Song WK, Chauhan N, Scalise PN, Agarwal R, Miller SD, et al. Quantification of particle-conjugated or particle-encapsulated peptides on interfering reagent backgrounds. Biotechniques. 2014;57:39\u201344.","journal-title":"Biotechniques"},{"key":"1708_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0378-1097(99)00536-4","volume":"182","author":"S Billington","year":"2000","unstructured":"Billington S. Thiol-activated cytolysins: structure, function and role in pathogenesis. FEMS Microbiol Lett. 2000;182:197\u2013205.","journal-title":"FEMS Microbiol Lett"},{"key":"1708_CR36","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1038\/s41598-017-02996-3","volume":"7","author":"W Mitsuwan","year":"2017","unstructured":"Mitsuwan W, Olaya-Abril A, Calder\u00f3n-Santiago M, Jim\u00e9nez-Mungu\u00eda I, Gonz\u00e1lez-Reyes JA, Priego-Capote F, et al. Integrated proteomic and metabolomic analysis reveals that rhodomyrtone reduces the capsule in Streptococcus pneumoniae. Sci Rep. 2017;7:2715.","journal-title":"Sci Rep"},{"key":"1708_CR37","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.3390\/molecules26113194","volume":"26","author":"SH Yu","year":"2021","unstructured":"Yu SH, Kumar M, Kim IW, Rimer JD, Kim TJ. A comparative analysis of in vitro toxicity of synthetic zeolites on IMR-90 human lung fibroblast cells. Molecules. 2021;26:3194.","journal-title":"Molecules"},{"key":"1708_CR38","doi-asserted-by":"publisher","first-page":"7627","DOI":"10.2147\/IJN.S263516","volume":"15","author":"ED Casta\u00f1eda-Reyes","year":"2020","unstructured":"Casta\u00f1eda-Reyes ED, Perea-Flores MJ, Davila-Ortiz G, Lee Y, Gonzalez de Mejia E. Development, characterization and use of liposomes as amphipathic transporters of bioactive compounds for melanoma treatment and reduction of skin inflammation: a review. Int J Nanomed. 2020;15:7627\u201350.","journal-title":"Int J Nanomed"},{"key":"1708_CR39","doi-asserted-by":"publisher","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8:e09394.","journal-title":"Heliyon"},{"key":"1708_CR40","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1038\/s41598-023-31895-z","volume":"13","author":"S Choi","year":"2023","unstructured":"Choi S, Kang B, Yang E, Kim K, Kwak MK, Chang PS, et al. Precise control of liposome size using characteristic time depends on solvent type and membrane properties. Sci Rep. 2023;13:4728.","journal-title":"Sci Rep"},{"key":"1708_CR41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12013-017-0792-7","volume":"75","author":"WK Subczynski","year":"2017","unstructured":"Subczynski WK, Pasenkiewicz-Gierula M, Widomska J, Mainali L, Raguz M. High cholesterol\/low cholesterol: effects in biological membranes review. Cell Biochem Biophys. 2017;75:369\u201385.","journal-title":"Cell Biochem Biophys"},{"key":"1708_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcis.2004.05.042","volume":"278","author":"X Liang","year":"2004","unstructured":"Liang X, Mao G, Ng KYS. Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy. J Colloid Interface Sci. 2004;278:53\u201362.","journal-title":"J Colloid Interface Sci"},{"key":"1708_CR43","doi-asserted-by":"publisher","first-page":"19637","DOI":"10.1021\/acsomega.4c01524","volume":"9","author":"EG Abucayon","year":"2024","unstructured":"Abucayon EG, Sweeney S, Matyas GR. A reliable quantification of cholesterol and 25-hydroxycholesterol in liposomal adjuvant formulation by liquid chromatography high-resolution tandem mass spectrometry. ACS Omega. 2024;9:19637\u201344.","journal-title":"ACS Omega"},{"key":"1708_CR44","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41467-020-15751-6","volume":"11","author":"LC Jacques","year":"2020","unstructured":"Jacques LC, Panagiotou S, Baltazar M, Senghore M, Khandaker S, Xu R, et al. Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin. Nat Commun. 2020;11:1892.","journal-title":"Nat Commun"},{"key":"1708_CR45","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1021\/bi9002309","volume":"48","author":"JJ Flanagan","year":"2009","unstructured":"Flanagan JJ, Tweten RK, Johnson AE, Heuck AP. Cholesterol exposure at the membrane surface is necessary and sufficient to trigger perfringolysin O binding. Biochemistry. 2009;48:3977\u201387.","journal-title":"Biochemistry"},{"key":"1708_CR46","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.3390\/ijms24032914","volume":"24","author":"IP S\u00e6b\u00f8","year":"2023","unstructured":"S\u00e6b\u00f8 IP, Bj\u00f8r\u00e5s M, Franzyk H, Helgesen E, Booth JA. Optimization of the hemolysis assay for the assessment of cytotoxicity. Int J Mol Sci. 2023;24:2914.","journal-title":"Int J Mol Sci"},{"key":"1708_CR47","doi-asserted-by":"publisher","first-page":"e04247","DOI":"10.7554\/eLife.04247","volume":"3","author":"C Leung","year":"2014","unstructured":"Leung C, Dudkina NV, Lukoyanova N, Hodel AW, Farabella I, Pandurangan AP, et al. Stepwise visualization of membrane pore formation by suilysin, a bacterial cholesterol-dependent cytolysin. eLife. 2014;3:e04247.","journal-title":"eLife"},{"key":"1708_CR48","doi-asserted-by":"publisher","first-page":"31218","DOI":"10.1074\/jbc.M303151200","volume":"278","author":"AP Heuck","year":"2003","unstructured":"Heuck AP, Tweten RK, Johnson AE. Assembly and topography of the prepore complex in cholesterol-dependent cytolysins. J Biol Chem. 2003;278:31218\u201325.","journal-title":"J Biol Chem"},{"key":"1708_CR49","doi-asserted-by":"publisher","first-page":"e02351","DOI":"10.1128\/mBio.02351-20","volume":"11","author":"JC Evans","year":"2020","unstructured":"Evans JC, Johnstone BA, Lawrence SL, Morton CJ, Christie MP, Parker MW, et al. A key motif in the cholesterol-dependent cytolysins reveals a large family of related proteins. mBio. 2020;11:e02351\u201320.","journal-title":"mBio"},{"key":"1708_CR50","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1038\/s41598-020-60348-0","volume":"10","author":"BHA Faraj","year":"2020","unstructured":"Faraj BHA, Collard L, Cliffe R, Blount LA, Lonnen R, Wallis R, et al. Formation of pre-pore complexes of pneumolysin is accompanied by a decrease in short-range order of lipid molecules throughout vesicle bilayers. Sci Rep. 2020;10:4585.","journal-title":"Sci Rep"},{"key":"1708_CR51","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0006-3495(99)76936-5","volume":"77","author":"R El Jastimi","year":"1999","unstructured":"El Jastimi R, Edwards K, Lafleur M. Characterization of permeability and morphological perturbations induced by nisin on phosphatidylcholine membranes. Biophys J. 1999;77:842\u201352.","journal-title":"Biophys J"},{"key":"1708_CR52","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1038\/s41467-024-47741-3","volume":"15","author":"UBA Aziz","year":"2024","unstructured":"Aziz UBA, Saoud A, Bermudez M, Mieth M, Atef A, Rudolf T, et al. Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxins. Nat Commun. 2024;15:3537.","journal-title":"Nat Commun"},{"key":"1708_CR53","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cell.2005.02.033","volume":"121","author":"SJ Tilley","year":"2005","unstructured":"Tilley SJ, Orlova EV, Gilbert RJC, Andrew PW, Saibil HR. Structural basis of pore formation by the bacterial toxin pneumolysin. Cell. 2005;121:247\u201356.","journal-title":"Cell"},{"key":"1708_CR54","doi-asserted-by":"publisher","first-page":"7915","DOI":"10.1021\/acs.nanolett.6b04219","volume":"16","author":"K van Pee","year":"2016","unstructured":"van Pee K, Mulvihill E, M\u00fcller DJ, Yildiz \u00d6. Unraveling the pore-forming steps of pneumolysin from Streptococcus pneumoniae. Nano Lett. 2016;16:7915\u201324.","journal-title":"Nano Lett"},{"key":"1708_CR55","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1039\/C9BM00134D","volume":"7","author":"P Dr\u00fccker","year":"2019","unstructured":"Dr\u00fccker P, Iacovache I, Bachler S, Zuber B, Babiychuk EB, Dittrich PS, et al. Membrane deformation and layer-by-layer peeling of giant vesicles induced by the pore-forming toxin pneumolysin. Biomater Sci. 2019;7:3693\u2013705.","journal-title":"Biomater Sci"},{"key":"1708_CR56","doi-asserted-by":"publisher","first-page":"e23644","DOI":"10.7554\/eLife.23644","volume":"6","author":"K van Pee","year":"2017","unstructured":"van Pee K, Neuhaus A, D\u2019Imprima E, Mills DJ, K\u00fchlbrandt W, Yildiz \u00d6. CryoEM structures of membrane pore and prepore complex reveal cytolytic mechanism of pneumolysin. eLife. 2017;6:e23644.","journal-title":"eLife"},{"key":"1708_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fphar.2018.00080","volume":"9","author":"AL Robson","year":"2018","unstructured":"Robson AL, Dastoor PC, Flynn J, Palmer W, Martin A, Smith DW, et al. Advantages and limitations of current imaging techniques for characterizing liposome morphology. Front Pharmacol. 2018;9:80.","journal-title":"Front Pharmacol"},{"key":"1708_CR58","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1086\/381972","volume":"38","author":"GA Pankey","year":"2004","unstructured":"Pankey GA, Sabath LD. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections. Clin Infect Dis. 2004;38:864\u201370.","journal-title":"Clin Infect Dis"},{"key":"1708_CR59","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.bpj.2015.01.020","volume":"108","author":"KM Scherer","year":"2015","unstructured":"Scherer KM, Spille JH, Sahl HG, Grein F, Kubitscheck U. The lantibiotic nisin induces lipid II aggregation, causing membrane instability and vesicle budding. Biophys J. 2015;108:1114\u201324.","journal-title":"Biophys J"},{"key":"1708_CR60","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1128\/JCM.39.3.1144-1147.2001","volume":"39","author":"CC Chiou","year":"2001","unstructured":"Chiou CC, McEllistrem MC. Novel penicillin-, cephalosporin-, and macrolide-resistant clones of Streptococcus pneumoniae serotypes 23F and 19F in Taiwan which differ from international epidemic clones. J Clin Microbiol. 2001;39:1144\u20137.","journal-title":"J Clin Microbiol"},{"key":"1708_CR61","doi-asserted-by":"publisher","first-page":"35442","DOI":"10.1021\/acsomega.3c04893","volume":"8","author":"R Ghosh","year":"2023","unstructured":"Ghosh R, De M. Liposome-based antibacterial delivery: an emergent approach to combat bacterial infections. ACS Omega. 2023;8:35442\u201351.","journal-title":"ACS Omega"},{"key":"1708_CR62","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3389\/fchem.2019.00872","volume":"7","author":"DY Wang","year":"2020","unstructured":"Wang DY, van der Mei HC, Ren Y, Busscher HJ, Shi L. Lipid-based antimicrobial delivery-systems for the treatment of bacterial infections. Front Chem. 2020;7:872.","journal-title":"Front Chem"},{"key":"1708_CR63","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/molecules28031498","volume":"28","author":"GYW Tseu","year":"2023","unstructured":"Tseu GYW, Kamaruzaman KA. A review of different types of liposomes and their advancements as a form of gene therapy treatment for breast cancer. Molecules. 2023;28:1498.","journal-title":"Molecules"},{"key":"1708_CR64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijpharm.2006.02.017","volume":"315","author":"Z Drulis-Kawa","year":"2006","unstructured":"Drulis-Kawa Z, Gubernator J, Dorotkiewicz-Jach A, Doroszkiewicz W, Kozubek A. In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains. Int J Pharm. 2006;315:59\u201366.","journal-title":"Int J Pharm"},{"key":"1708_CR65","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/molecules27041372","volume":"27","author":"P Liu","year":"2022","unstructured":"Liu P, Chen G, Zhang J. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022;27:1372.","journal-title":"Molecules"},{"key":"1708_CR66","doi-asserted-by":"publisher","first-page":"1005918","DOI":"10.3389\/fbioe.2022.1005918","volume":"10","author":"D Lahiri","year":"2022","unstructured":"Lahiri D, Nag M, Dutta B, Sarkar T, Pati S, Basu D, et al. Bacteriocin: a natural approach for food safety and food security. Front Bioeng Biotechnol. 2022;10:1005918.","journal-title":"Front Bioeng Biotechnol"},{"key":"1708_CR67","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/antibiotics9060305","volume":"9","author":"E Twomey","year":"2020","unstructured":"Twomey E, Hill C, Field D, Begley M. Bioengineered nisin derivative M17Q has enhanced activity against Staphylococcus epidermidis. Antibiotics. 2020;9:305.","journal-title":"Antibiotics"},{"key":"1708_CR68","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00284-017-1375-y","volume":"75","author":"H Chi","year":"2018","unstructured":"Chi H, Holo H. Synergistic antimicrobial activity between the broad spectrum bacteriocin garvicin KS and nisin, farnesol and polymyxin B against gram-positive and gram-negative bacteria. Curr Microbiol. 2018;75:272\u20137.","journal-title":"Curr Microbiol"},{"key":"1708_CR69","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3389\/fmicb.2020.01007","volume":"11","author":"C Jensen","year":"2020","unstructured":"Jensen C, Li H, Vestergaard M, Dalsgaard A, Frees D, Leisner JJ. Nisin damages the septal membrane and triggers DNA condensation in methicillin-resistant Staphylococcus aureus. Front Microbiol. 2020;11:1007.","journal-title":"Front Microbiol"},{"key":"1708_CR70","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.3390\/cancers14194758","volume":"14","author":"AM Molujin","year":"2022","unstructured":"Molujin AM, Abbasiliasi S, Nurdin A, Lee PC, Gansau JA, Jawan R. Bacteriocins as potential therapeutic approaches in the treatment of various cancers: a review of in vitro studies. Cancers. 2022;14:4758.","journal-title":"Cancers"},{"key":"1708_CR71","doi-asserted-by":"publisher","first-page":"847","DOI":"10.4315\/0362-028X-66.5.847","volume":"66","author":"SE Murinda","year":"2003","unstructured":"Murinda SE, Rashid KA, Roberts RF. In vitro assessment of the cytotoxicity of nisin, pediocin, and selected colicins on simian virus 40-transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays. J Food Prot. 2003;66:847\u201353.","journal-title":"J Food Prot"},{"key":"1708_CR72","doi-asserted-by":"publisher","first-page":"e0131008","DOI":"10.1371\/journal.pone.0131008","volume":"10","author":"P Kamarajan","year":"2015","unstructured":"Kamarajan P, Hayami T, Matte B, Liu Y, Danciu T, Ramamoorthy A, et al. Nisin ZP, a bacteriocin and food preservative, inhibits head and neck cancer tumorigenesis and prolongs survival. PLoS ONE. 2015;10:e0131008.","journal-title":"PLoS ONE"},{"key":"1708_CR73","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1099\/mic.0.062190-0","volume":"158","author":"AD Paiva","year":"2012","unstructured":"Paiva AD, de Oliveira MD, de Paula SO, Baracat-Pereira MC, Breukink E, Mantovani HC. Toxicity of bovicin HC5 against mammalian cell lines and the role of cholesterol in bacteriocin activity. Microbiology. 2012;158:2851\u20138.","journal-title":"Microbiology"},{"key":"1708_CR74","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/nano10020190","volume":"10","author":"CT Inglut","year":"2020","unstructured":"Inglut CT, Sorrin AJ, Kuruppu T, Vig S, Cicalo J, Ahmad H, et al. Immunological and toxicological considerations for the design of liposomes. Nanomaterials. 2020;10:190.","journal-title":"Nanomaterials"},{"key":"1708_CR75","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.fct.2018.05.059","volume":"118","author":"L Maldonado-Pereira","year":"2018","unstructured":"Maldonado-Pereira L, Schweiss M, Barnaba C, Medina-Meza IG. The role of cholesterol oxidation products in food toxicity. Food Chem Toxicol. 2018;118:908\u201339.","journal-title":"Food Chem Toxicol"},{"key":"1708_CR76","doi-asserted-by":"publisher","first-page":"e0201530","DOI":"10.1371\/journal.pone.0201530","volume":"13","author":"R Rashwan","year":"2018","unstructured":"Rashwan R, Varano della Vergiliana JF, Lansley SM, Cheah HM, Popowicz N, Paton JC, et al. Streptococcus pneumoniae potently induces cell death in mesothelial cells. PLoS ONE. 2018;13:e0201530.","journal-title":"PLoS ONE"},{"key":"1708_CR77","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nrmicro2182","volume":"7","author":"M Otto","year":"2009","unstructured":"Otto M. Staphylococcus epidermidis\u2013 the accidental pathogen. Nat Rev Microbiol. 2009;7:555\u201367.","journal-title":"Nat Rev Microbiol"},{"key":"1708_CR78","doi-asserted-by":"publisher","first-page":"22972","DOI":"10.1038\/srep22972","volume":"6","author":"P Rai","year":"2016","unstructured":"Rai P, He F, Kwang J, Engelward BP, Chow VTK. Pneumococcal pneumolysin induces DNA damage and cell cycle arrest. Sci Rep. 2016;6:22972.","journal-title":"Sci Rep"},{"key":"1708_CR79","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.cmet.2021.09.001","volume":"33","author":"Y Song","year":"2021","unstructured":"Song Y, Liu J, Zhao K, Gao L, Zhao J. Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases. Cell Metab. 2021;33:1911\u201325.","journal-title":"Cell Metab"},{"key":"1708_CR80","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/0005-2736(89)90404-5","volume":"980","author":"FH Roerdink","year":"1989","unstructured":"Roerdink FH, Regts J, Handel T, Sullivan SM, Baldeschwieler JD, Scherphof GL. Effect of cholesterol on the uptake and intracellular degradation of liposomes by liver and spleen; a combined biochemical and \u03b3-ray perturbed angular correlation study. Biochim Biophys Acta - Biomembr. 1989;980:234\u201340.","journal-title":"Biochim Biophys Acta - Biomembr"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01708-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01708-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01708-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T01:45:40Z","timestamp":1743903940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01708-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1708"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01708-5","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"4 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All conducted experiments comply with current Canadian laws. Ethical approval and consent to participate was not applicable for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We certify that this paper consists of original and unpublished work, with all authors having read and approved the final version of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No animal or human studies were carried out by the authors for this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"Author E.W. and Author E.A.H. are listed as co-inventors on a pending patent involved with this work (US 63\/577,061). Author I.A. declares that they have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}